These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18422076)

  • 1. [Seroconversion of hepatitis C in blood donors].
    Pascuccio MS; Gendler SA; Carnevali L; Fuse V
    Medicina (B Aires); 2007; 67(6 Pt 2):771-2. PubMed ID: 18422076
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
    Alvarez M; Planelles D; Vila E; Montoro J; Franco E
    Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
    [No Abstract]   [Full Text] [Related]  

  • 3. Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
    Laperche S; Bouchardeau F; Maniez M; Béolet M; Elghouzzi MH; Lefrère JJ
    Vox Sang; 2004 Apr; 86(3):198. PubMed ID: 15078255
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of hepatitis C virus and human immunodeficiency virus-1 antibody-negative donations: Canadian Blood Services' experience with nucleic acid testing.
    O'Brien SF; Fan W; Scalia V; Goldman M; Fearon MA; Vamvakas EC
    Vox Sang; 2006 Apr; 90(3):204. PubMed ID: 16507022
    [No Abstract]   [Full Text] [Related]  

  • 5. Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples.
    Schmidt M; Weber M; Busch MP; Tobler LH; Phelps BH; Seifried E; Roth WK
    Transfusion; 2005 Jun; 45(6):1040-2. PubMed ID: 15935008
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1 and HCV infections among antibody-negative blood donors.
    Laperche S; Pillonel J; Herve P
    N Engl J Med; 2004 Nov; 351(21):2232-5; author reply 2232-5. PubMed ID: 15559959
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C test results do not justify claim of test equivalence nor of prolonged seroconversion.
    Caspari G
    Vox Sang; 2005 Apr; 88(3):205. PubMed ID: 15787733
    [No Abstract]   [Full Text] [Related]  

  • 8. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donors.
    Bryan CF; Tegtmeier GE; Polito A; Bayer W; Pierce GE; Shield CF; Warady BA; Aeder MI; Borkon AM; Estep TH; Forster J; Landreneau MD; Luger AM; Nelson PW; Ross G
    Transplant Proc; 1996 Feb; 28(1):155-6. PubMed ID: 8644153
    [No Abstract]   [Full Text] [Related]  

  • 10. HCV positivity rate in the seronegative blood donors in China.
    Yang Z; Han YX; Jiang JD; Yang Z; Yu YX; Qiu Y
    Biomed Pharmacother; 2009 May; 63(4):319-20. PubMed ID: 19246175
    [No Abstract]   [Full Text] [Related]  

  • 11. [Laboratory test for hepatitis C should be more reliable].
    Xing WG; Zheng HJ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):170-1. PubMed ID: 15059306
    [No Abstract]   [Full Text] [Related]  

  • 12. The first case of HCV infection detected before seroconversion in blood donors tested by HCV core antigen ELISA.
    Sanz C; Tassies D; Costa J; Freire C; Pereira A
    Transfusion; 2002 Apr; 42(4):505-6. PubMed ID: 12076300
    [No Abstract]   [Full Text] [Related]  

  • 13. [HCV genotypes in Polish blood donors in period 1995-2007].
    Brojer E; Grabarczyk P; Kopacz A; Potepa A; Medyńska J; Smolarczyk-Wodzyńska J; Letowska M
    Przegl Epidemiol; 2008; 62(1):163-9. PubMed ID: 18536240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of antibodies to the envelope glycoproteins of hepatitis C virus in immunoglobulin preparations from screened donors.
    Piazza M; Chien D; Quan S; Houghton M
    Boll Soc Ital Biol Sper; 1996; 72(1-2):69-70. PubMed ID: 8868116
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of anti-HC in relatives of carriers as a way of detecting new cases].
    Vilar JH; Rivera MA; Rodríguez A; Valiensi SM; Tejada de Martínez R; Lanari Zubiaur FJ
    Acta Gastroenterol Latinoam; 2000; 30(5):497-500. PubMed ID: 11144945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of antibody to hepatitis C virus in blood donors. Analysis of confirmed results].
    Wolff C; Jirón MI; Elgueta R; Vera M; Toriello L; Martínez L; Parraguez A
    Rev Med Chil; 1996 May; 124(5):615-6. PubMed ID: 9035517
    [No Abstract]   [Full Text] [Related]  

  • 17. [Detection of hepatitis C virus in the general population of Tunisia].
    Gorgi Y; Yalaoui S; Ben Nejma HL; Azzouz MM; Hsairi M; Ben Khelifa H; Ayed K
    Bull Soc Pathol Exot; 1998; 91(2):177. PubMed ID: 9642480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Towards research on hepatitis C].
    Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):65-6. PubMed ID: 14980099
    [No Abstract]   [Full Text] [Related]  

  • 19. Specificity of immunoblot assay in hepatitis--C ELISA positive patients and carriers.
    Oberoi A; Aggarwal A
    Indian J Pathol Microbiol; 2006 Apr; 49(2):310-1. PubMed ID: 16933752
    [No Abstract]   [Full Text] [Related]  

  • 20. First fully automated blood screening test for HCV antibodies approved.
    AIDS Patient Care STDS; 2007 Aug; 21(8):608. PubMed ID: 17902247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.